Yvonne Döring Selected Research

Yvonne Döring Research Topics

Disease

44	Atherosclerosis 04/2024 - 07/2011
17	Inflammation (Inflammations) 04/2024 - 07/2012
12	Atherosclerotic Plaque (Atheroma) 01/2023 - 10/2011
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2014
9	Thrombosis (Thrombus) 04/2022 - 10/2011
5	Infections 01/2022 - 06/2007
4	Muscle Cramp (Cramp) 03/2013 - 10/2011
3	Obesity 01/2023 - 10/2016
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 06/2007
3	Acute Lung Injury 01/2017 - 04/2014
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 10/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 10/2016
2	Hyperlipidemias (Hyperlipidemia) 04/2021 - 10/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 01/2015
2	Hypercholesterolemia 02/2017 - 03/2013
2	Lung Injury 01/2016 - 04/2014
2	Pathologic Constriction (Stenosis) 01/2015 - 10/2011
2	Neointima 06/2014 - 10/2011
2	Hyperplasia 06/2014 - 10/2011
2	Virus Diseases (Viral Diseases) 01/2012 - 06/2007
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Hypertrophy 01/2022
1	Cicatrix (Scar) 01/2022
1	Vascular Remodeling 01/2022
1	Neuroinflammatory Diseases 03/2021
1	Alzheimer Disease (Alzheimer's Disease) 03/2021
1	Neoplasms (Cancer) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	COVID-19 12/2020
1	Diabetes Mellitus 01/2020
1	Necrosis 12/2019

Drug/Important Bio-Agent (IBA)

15	ChemokinesIBA 04/2024 - 01/2014
13	Apolipoproteins E (ApoE)IBA 11/2023 - 04/2012
7	Chemokine ReceptorsIBA 01/2023 - 03/2014
7	LipidsIBA 01/2023 - 07/2012
6	CytokinesIBA 04/2024 - 07/2012
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2010
4	ApolipoproteinsIBA 12/2017 - 04/2012
3	Peptides (Polypeptides)IBA 01/2023 - 01/2017
3	LDL Receptors (LDL Receptor)IBA 01/2023 - 10/2019
3	Phosphotransferases (Kinase)IBA 01/2020 - 01/2014
3	LigandsIBA 02/2015 - 01/2014
3	CathelicidinsIBA 03/2013 - 10/2011
2	Hormones (Hormone)IBA 01/2023 - 10/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2020
2	CholesterolIBA 10/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2018
2	Histones (Histone)IBA 01/2021 - 01/2016
2	LipopolysaccharidesIBA 01/2021 - 10/2016
2	Immunoglobulin M (IgM)IBA 01/2020 - 01/2020
2	canakinumab FDA Link 12/2019 - 01/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 04/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2012
2	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2018 - 05/2016
2	AntibodiesIBA 04/2012 - 01/2008
2	Interferon Type IIBA 04/2012 - 01/2012
2	Antiphospholipid AntibodiesIBA 03/2010 - 06/2007
1	Lipoproteins (Lipoprotein)IBA 04/2024
1	MicroRNAs (MicroRNA)IBA 11/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Testosterone (Sustanon)FDA Link 01/2023
1	gastric inhibitory polypeptide receptorIBA 01/2023
1	PropionatesIBA 10/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	peptide IIBA 01/2022
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2022
1	Apolipoprotein E4IBA 03/2021
1	CurcuminIBA 03/2021
1	Semaxinib (SU5416)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Calcium-Sensing ReceptorsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Galectins (Galectin)IBA 01/2020
1	CollagenIBA 01/2020
1	glucagon-like peptide-1 (9-36)IBA 01/2020
1	Threonine (L-Threonine)FDA Link 12/2019
1	Serine (L-Serine)FDA Link 12/2019
1	Collagen Type III (Type III Collagen)IBA 10/2019
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2018
1	InflammasomesIBA 01/2018
1	Tryptophan HydroxylaseIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 01/2018
1	Scarlet Red (Sudan IV)IBA 12/2017
1	Mannose ReceptorIBA 12/2017
1	LDL CholesterolIBA 02/2017
1	human neutrophil peptide 1IBA 02/2017
1	oxidized low density lipoproteinIBA 02/2017
1	68Ga-pentixaforIBA 01/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2017

Therapy/Procedure

7	Therapeutics 04/2024 - 07/2011
2	Immunotherapy 01/2021 - 12/2019
1	Subcutaneous Injections 01/2023
1	Art Therapy 01/2018